These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10454142)

  • 1. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease.
    Mogi M; Togari A; Kondo T; Mizuno Y; Komure O; Kuno S; Ichinose H; Nagatsu T
    Neurosci Lett; 1999 Jul; 270(1):45-8. PubMed ID: 10454142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cell line-derived neurotrophic factor in the substantia nigra from control and parkinsonian brains.
    Mogi M; Togari A; Kondo T; Mizuno Y; Kogure O; Kuno S; Ichinose H; Nagatsu T
    Neurosci Lett; 2001 Mar; 300(3):179-81. PubMed ID: 11226640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
    Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
    Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M; Kondo T; Mizuno Y; Nagatsu T
    Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cytokines and neurotrophins in Parkinson's disease.
    Nagatsu T; Mogi M; Ichinose H; Togari A
    J Neural Transm Suppl; 2000; (60):277-90. PubMed ID: 11205147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain. Short communication.
    Mogi M; Harada M; Kondo T; Riederer P; Nagatsu T
    J Neural Transm (Vienna); 1996; 103(8-9):1077-81. PubMed ID: 9013395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
    Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
    Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.
    Bossers K; Meerhoff G; Balesar R; van Dongen JW; Kruse CG; Swaab DF; Verhaagen J
    Brain Pathol; 2009 Jan; 19(1):91-107. PubMed ID: 18462474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system.
    Paumier KL; Sortwell CE; Madhavan L; Terpstra B; Daley BF; Collier TJ
    Exp Neurol; 2015 Apr; 266():11-21. PubMed ID: 25681575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.
    Parain K; Murer MG; Yan Q; Faucheux B; Agid Y; Hirsch E; Raisman-Vozari R
    Neuroreport; 1999 Feb; 10(3):557-61. PubMed ID: 10208589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain.
    Chauhan NB; Siegel GJ; Lee JM
    J Chem Neuroanat; 2001 Jun; 21(4):277-88. PubMed ID: 11429269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
    Nishino N; Noguchi-Kuno SA; Sugiyama T; Tanaka C
    Brain Res; 1986 Jul; 377(1):186-9. PubMed ID: 2942224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients.
    Mogi M; Harada M; Kondo T; Riederer P; Inagaki H; Minami M; Nagatsu T
    Neurosci Lett; 1994 Oct; 180(2):147-50. PubMed ID: 7700568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.
    Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Tanaka K
    Brain; 2001 Apr; 124(Pt 4):784-92. PubMed ID: 11287377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain.
    Mogi M; Togari A; Kondo T; Mizuno Y; Komure O; Kuno S; Ichinose H; Nagatsu T
    J Neural Transm (Vienna); 2000; 107(3):335-41. PubMed ID: 10821442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
    Quik M; Spokes EG; Mackay AV; Bannister R
    J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra.
    Knott C; Stern G; Kingsbury A; Welcher AA; Wilkin GP
    Parkinsonism Relat Disord; 2002 Jun; 8(5):329-41. PubMed ID: 15177062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease.
    Virachit S; Mathews KJ; Cottam V; Werry E; Galli E; Rappou E; Lindholm P; Saarma M; Halliday GM; Shannon Weickert C; Double KL
    Brain Pathol; 2019 Nov; 29(6):813-825. PubMed ID: 31033033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.